Cargando…

Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells

In this study, we investigated the effects of a selective urotensin II (UII) receptor antagonist, SB-657510, on the inflammatory response induced by UII in human umbilical vein endothelial cells (EA.hy926) and human monocytes (U937). UII induced inflammatory activation of endothelial cells through e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sung Lyea, Lee, Bo Kyung, Kim, Young-Ae, Lee, Byung Ho, Jung, Yi-Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819900/ https://www.ncbi.nlm.nih.gov/pubmed/24244812 http://dx.doi.org/10.4062/biomolther.2013.051

Ejemplares similares

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
por: Kim, Young-Ae, et al.
Publicado: (2016)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
por: Portnoy, Alison, et al.
Publicado: (2013)

A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway
por: Kim, Tae-Ho, et al.
Publicado: (2017)

Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008)

The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
por: ZHAO, JUAN, et al.
Publicado: (2013)

Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

Identification of new target proteins of a Urotensin-II receptor antagonist using transcriptome-based drug repositioning approach
por: Lim, Gyutae, et al.
Publicado: (2021)

The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification
por: Albanese, Isabella, et al.
Publicado: (2016)

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014)

Urotensin-II: More Than a Mediator for Kidney
por: Balat, Ayşe, et al.
Publicado: (2012)

Role of Urotensin-II in Saphenous Vein Graft Disease
por: Tüysüz, Mehmet Erin, et al.
Publicado: (2020)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
por: Ogawa, Akiko, et al.
Publicado: (2023)

Protective effect of urotensin II receptor antagonist urantide and exercise training on doxorubicin-induced cardiotoxicity
por: Sun, Jing, et al.
Publicado: (2023)

Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells
por: Iglewski, Myriam, et al.
Publicado: (2010)

Urotensin II Induces Interleukin 8 Expression in Human Umbilical Vein Endothelial Cells
por: Lee, Chung-Yi, et al.
Publicado: (2014)

The urotensin II receptor antagonist DS37001789 ameliorates mortality in pressure-overload mice with heart failure
por: Nishi, Mina, et al.
Publicado: (2020)

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
por: Merlino, Francesco, et al.
Publicado: (2013)

A closer look at the role of urotensin II in the metabolic syndrome
por: Barrette, Pierre-Olivier, et al.
Publicado: (2012)

Urotensin II in Invertebrates: From Structure to Function in Aplysia californica
por: Romanova, Elena V., et al.
Publicado: (2012)

Irisin levels are associated with urotensin II levels in diabetic patients
por: He, Wan-Yu, et al.
Publicado: (2015)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
por: Simunovic, Marko, et al.
Publicado: (2022)

Urotensin II level is elevated in inflammatory bowel disease patients
por: Zhang, Yan, et al.
Publicado: (2022)

Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels
por: Oral, Elif, et al.
Publicado: (2019)

The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer
por: Balakan, Ozan, et al.
Publicado: (2014)

Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients
por: Wei, Hongtao, et al.
Publicado: (2017)

Urotensin II levels in patients with chronic kidney disease and kidney transplants
por: Hursitoglu, Mehmet, et al.
Publicado: (2012)

Urotensin-II System in Genetic Control of Blood Pressure and Renal Function
por: Debiec, Radoslaw, et al.
Publicado: (2013)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

The value of urotensin II in patients with left-sided rheumatic valvular regurgitation
por: Elmadbouh, Ibrahim, et al.
Publicado: (2017)

Urotensin II promotes aldosterone expression in rat aortic adventitial fibroblasts
por: Li, Jun, et al.
Publicado: (2018)

Expression of urotensin II is associated with placental autophagy in patients with severe preeclampsia
por: Pan, Ya-Jing, et al.
Publicado: (2018)

Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea
por: Mihovilovic, Ante, et al.
Publicado: (2023)

Correction: Urotensin II Induces Interleukin 8 Expression in Human Umbilical Vein Endothelial Cells
Publicado: (2014)

Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes
por: Chao, Hung-Hsing, et al.
Publicado: (2014)

Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2
por: Goldberg, Alexander A., et al.
Publicado: (2016)

Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion
por: Franco, Renato, et al.
Publicado: (2014)

Endogenous Urotensin II Selectively Modulates Erectile Function through eNOS
por: d'Emmanuele di Villa Bianca, Roberta, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hop6q15esvg1fv087njbcaeeni